The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Abbott Laboratories (NYSE:ABT), Gilead Sciences (NASDAQ:GILD), Southern Company (The) (NYSE:SO), McKesson Corp (NYSE:MCK).
The investment seeks to achieve capital appreciation through all market cycles.
The fund seeks to achieve its investment objective by investing, under normal circumstances, a range of approximately 70% to 100% of its net assets in a portfolio of defensive, non-cyclical equity securities of foreign and domestic companies selected by applying a rules-based strategy. Equity securities include common stock. The fund may target having approximately 0% to 30% of its assets in short positions under normal market conditions.
The average market capitalization across the AmericaFirst Defensive Growth U MF is 47.64B. The market cap for tickers in the group ranges from 27.85B to 561.54B. LLY holds the highest valuation in this group at 561.54B. The lowest valued company is VEEV at 27.85B.
The average weekly volume growth across all stocks in the AmericaFirst Defensive Growth U MF was -28%. For the same stocks of the MF, the average monthly volume growth was -59% and the average quarterly volume growth was -39%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 56
P/E Growth Rating: 54
Price Growth Rating: 53
SMR Rating: 58
Profit Risk Rating: 54
Seasonality Score: 0 (-100 ... +100)